Société des Produits Nestlé (SPN)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Société des Produits Nestlé (SPN) sits in the top decile of US sponsors by registered trial count (#359 of 15,742 sponsors by registered trial count).
Société des Produits Nestlé (SPN): 53 sponsored US clinical trials, 1 recruiting.
Société des Produits Nestlé (SPN) sponsors 53 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 48 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Dietary Supplement, with 2 trials.
Top-decile sponsor footprint
Société des Produits Nestlé (SPN) ranks in the top decile of sponsors by registered trial count (#359 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
48 of 52 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
53 total, page 1 of 2
Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)
NCT06347315
To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO
NCT05963594
Ability to Meet Enteral Nutritional Needs with a Peptide-based, High Protein Formula
NCT05025267
Glycemic Response in Adults with Diabetes
NCT05026424
Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia
NCT04877366
Glucose Response in Persons with Type 2 Diabetes
NCT04914559
A Study to Evaluate the Effects of Pre-Meal Whey Protein Microgels Administration on Post-Prandial Glycemic Response.
NCT04639726
Glycemic Response in Persons with Type 2 Diabetes
NCT04413357
Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG)
NCT04516213
Impact of Infant Formula on Caregiver-perceived Intolerance
NCT03679234
Retrospective Review of Amino Acid Formula Use at a Children's Center
NCT03497091
Novel Mobile Application to Assess Dietary Information
NCT03578458
Glycemic Response in Persons With Type 2 Diabetes Mellitus
NCT04168541
Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding
NCT03017664
Videofluoroscopic Swallowing Study (VFSS)
NCT03387267
Gastrointestinal Tolerance Evaluation of an Infant Formula
NCT03307122
Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula
NCT03236207
Glycemic Response to Six Meal Replacements in Persons With Type 2 Diabetes Mellitus
NCT03155867
Infant Nutrition and Brain Development
NCT03111927
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
NCT02953223
An Evaluation of Omega-3 Fatty Acid
NCT03017651
Protein Consumption in Critically Ill Patients
NCT03048487
Glycemic Response to Two Enteral Formulas in Persons With Type 2 Diabetes Mellitus
NCT02898766
Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus
NCT02856516
Tolerance of a Calorically Dense Enteral Nutrition Formula
NCT02806427
Enteral Formula Tolerance in Pediatric Patients
NCT02779335
Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
NCT02635698
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula
NCT02450643
Feeding Tolerance Evaluation
NCT02405572
Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay
NCT02912065
Enteral Formula Tolerance of Standard Tube Feedings
NCT02312271
The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU
NCT02337556
Feasibility Clinical Study of NLA Tool-US
NCT01995682
Chewing Capability Study for Infants and Toddlers
NCT02156986
Glycemic Response to Oral Nutrition Supplements
NCT02612675
Growth of Infants Fed an Amino Acid Infant Formula
NCT01583673
Elemental Formula Hypoallergenicity
NCT01569776
Probiotic Formula and Infant Growth
NCT01476397
Feeding Trial in Pediatric Patients
NCT01469117
Effect of the Level of Dietary Protein on Body Composition
NCT01489098
Validation of a Nutrition Screening Tool
NCT01473706
Feeding Trial in the Obese Critical Care Population
NCT01357200
Extensively Hydrolyzed Formula: Hypoallergenicity
NCT01278446
Growth of Infants Fed an Extensively Hydrolyzed Infant Formula
NCT01210391
Preterm Infant Growth
NCT01162798
Growth of Infants Fed New Starter Formula
NCT01079208
Assessment of Growth of Infants Fed a New Formula
NCT00937014
Feeding Intervention for Infants With Crying
NCT01017991
Evaluation of a Weight Management Program
NCT00888251
Effect of the Level of Dietary Protein on Infant Growth
NCT00716105
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
What is open in the Société des Produits Nestlé (SPN) pipeline
1 recruiting of 53 indexed (2% open); 48 completed (91%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Dietary Supplement (2 trials), 8 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Société des Produits Nestlé (SPN): open-pipeline peers nationwide
Peers matched on 53 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Société des Produits Nestlé (SPN) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 53 trials (± recruiting share)
- BioNTech SE · 53 trials · 36% recruiting
- Warner Chilcott · 53 trials · 0% recruiting
- W.L.Gore & Associates · 53 trials · 21% recruiting
- AdventHealth Translational Research Institute · 54 trials · 24% recruiting
Sponsors near 2% open enrollment (± trial volume)
- PTC Therapeutics · 2% recruiting · 52 trials
- Spectrum Pharmaceuticals · 2% recruiting · 52 trials
- Alcon Research · 2% recruiting · 275 trials
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · 2% recruiting · 55 trials
Related
What to do with this Société des Produits Nestlé (SPN) page
53 registered trials is a research-attention snapshot, not an endorsement of Société des Produits Nestlé (SPN) or any single study.
- 1 of Société des Produits Nestlé (SPN)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Dietary Supplement is the condition Société des Produits Nestlé (SPN) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dietary Supplement trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Société des Produits Nestlé (SPN) pipeline card: 53 registered trials from official public datasets.Report a data error.